These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6982737

  • 1. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
    Ruggeri ZM, Lombardi R, Gatti L, Bader R, Valsecchi C, Zimmerman TS.
    Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
    [Abstract] [Full Text] [Related]

  • 2. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS.
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [Abstract] [Full Text] [Related]

  • 3. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjörin E.
    N Engl J Med; 1983 Oct 06; 309(14):816-21. PubMed ID: 6412139
    [Abstract] [Full Text] [Related]

  • 4. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S, Yoshioka K, Kasahara M, Takamiya O.
    Am J Hematol; 1992 Jul 06; 40(3):192-8. PubMed ID: 1609773
    [Abstract] [Full Text] [Related]

  • 5. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).
    Ruggeri ZM, Nilsson IM, Lombardi R, Holmberg L, Zimmerman TS.
    J Clin Invest; 1982 Nov 06; 70(5):1124-7. PubMed ID: 6982283
    [Abstract] [Full Text] [Related]

  • 6. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM, Zimmerman TS.
    J Clin Invest; 1980 Jun 06; 65(6):1318-25. PubMed ID: 6773982
    [Abstract] [Full Text] [Related]

  • 7. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP, Montgomery RR.
    Am J Clin Pathol; 1991 Dec 06; 96(6):723-8. PubMed ID: 1746488
    [Abstract] [Full Text] [Related]

  • 8. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L, Kristoffersson AC, Lamme S, Nilsson IM, Awidi A, Solum NO.
    Scand J Haematol; 1985 Sep 06; 35(3):305-14. PubMed ID: 3877338
    [Abstract] [Full Text] [Related]

  • 9. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS.
    N Engl J Med; 1980 May 08; 302(19):1047-51. PubMed ID: 6767976
    [Abstract] [Full Text] [Related]

  • 10. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
    Holmberg L, Berntorp E, Donnér M, Nilsson IM.
    Blood; 1986 Sep 08; 68(3):668-72. PubMed ID: 3488775
    [Abstract] [Full Text] [Related]

  • 11. Response to desmopressin in type IID von Willebrand's disease.
    Thomas N, O'Callaghan U, Lowe GD, Olszynski V, Kernoff PB, Abildgaard CF, Tuddenham EG.
    Clin Lab Haematol; 1989 Sep 08; 11(3):189-97. PubMed ID: 2591151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
    Goudemand J, Samor B, Caron C, Jude B, Gosset D, Mazurier C.
    Br J Haematol; 1988 Feb 11; 68(2):227-33. PubMed ID: 3126793
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR, Williams SB, Shafer BC, Corash L.
    Blood; 1982 Aug 11; 60(2):328-32. PubMed ID: 6807372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure and function of von Willebrand factor: relationship to von Willebrand's disease.
    Ruggeri ZM.
    Mayo Clin Proc; 1991 Aug 11; 66(8):847-61. PubMed ID: 1907344
    [Abstract] [Full Text] [Related]

  • 19. Platelet activation and alpha granule secretion in type IIB von Willebrand's disease.
    Gralnick HR, Williams S, McKeown LP, Connaghan G, Shafer B, Hansmann K, Magruder L, Vail M.
    Br J Haematol; 1991 Dec 11; 79(4):618-23. PubMed ID: 1722992
    [Abstract] [Full Text] [Related]

  • 20. Further characterization of platelet-type von Willebrand's disease in Japan.
    Takahashi H, Handa M, Watanabe K, Ando Y, Nagayama R, Hattori A, Shibata A, Federici AB, Ruggeri ZM, Zimmerman TS.
    Blood; 1984 Dec 11; 64(6):1254-62. PubMed ID: 6333901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.